FDA rare-disease shift, new Zepbound launch and 340B pressure headline today’s news
February 23, 2026

1. Hospitals urge HHS to extend comment deadline on 340B rebate pilot Full story

2. Eli Lilly launches new form of Zepbound Full story

3. Outpatient + specialty pharmacies face new 340B billing challenges. See what's changing here.

 

4. Louisiana reaches $45M settlement with CVS Full story

5. FDA unveils pathway for ultra-rare disease therapies Full story

6. Procurement isn't purchasing anymore. Vernon Memorial Healthcare's connected strategy here.

 

7. HHS invests $15M to bolster US supply of Tamiflu Full story

8. Walgreens to cut 628 jobs Full story

9. WVU Cancer Institute achieves immunotherapy 1st: What to know Full story

10. 165 top places to work in healthcare | 2026 Full story

11. Historic New York City nurses strike ends after 41 days Full story

 

12. Fragmented pharmacy procurement drives margin loss + oversight gaps at health systems. Find another way: here.

Becker's Learning Opportunities

13. How a 14-hospital system uncovered $3.5M in pharmacy savings. See the case study here.

14. How 3 leading systems united finance, pharmacy + cardiology to expand care access: here.

15. Half of specialty patients still fill scripts outside health systems. What's driving leakage: here.

16. Interested in more? See Becker’s full lineup of webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 
 

 

Contact Us, Feedback, or Questions – Email ptwenter@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication